Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma

Junshang Ge1,2,3, Yi Meng1,2,3, Jiayue Guo1,2,3

  • 1Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Nature Communications
|October 4, 2024
PubMed

Insights

Human Papillomavirus (HPV) circE7 RNA hinders anti-tumor immunity in head and neck cancer by reducing CD8+ T cell activity. This suggests combined PD-1 and TIM-3 inhibition as a potential HNSCC immunotherapy.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Immune evasion is critical in cancer progression and a target for immunotherapy.
  • Human Papillomavirus (HPV) is implicated in head and neck squamous cell carcinoma (HNSCC).

Purpose of the Study:

  • To investigate the role of HPV-encoded circE7 in HNSCC immune evasion.
  • To elucidate the molecular mechanism by which circE7 affects T cell activity and explore potential immunotherapeutic strategies.

Main Methods:

  • In vitro and in vivo experiments were conducted.
  • Assessed the association between circE7 and CD8+ T cell infiltration in HNSCC.
  • Investigated the molecular pathway involving circE7, ACC1, LGALS9, galectin-9, TIM-3, and PD-1.

Main Results:

  • A negative correlation was found between HPV circE7 and CD8+ T cell infiltration in HNSCC.
  • circE7 suppresses T cell function by downregulating galectin-9 via epigenetic modification of the LGALS9 gene.
  • Galectin-9 interacts with TIM-3 and PD-1, inhibiting T cell cytokine secretion and promoting apoptosis.

Conclusions:

  • HPV circE7 promotes immune evasion in HNSCC through epigenetic regulation.
  • Combined anti-PD-1 and anti-TIM-3 therapy is proposed as a potential immunotherapy for HNSCC.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.0K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
5
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K